BIOMAT Database Logo BIOMAT Database Logo

[Prodigiosan aerosaol therapy of patients with destructive forms of pulmonary tuberculosis]. 1974

V T Kornienko, and L A Taranenko

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011353 Prodigiosin 4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)- 2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

V T Kornienko, and L A Taranenko
[Intermittent therapy of chronic destructive forms of pulmonary tuberculosis].
August 1980, Vrachebnoe delo,
V T Kornienko, and L A Taranenko
[Characteristics of patients' populations with destructive forms of pulmonary tuberculosis].
January 1973, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis].
January 1988, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Intravenous chemotherapy of patients with destructive forms of pulmonary tuberculosis].
January 1971, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Endobronchial treatment of patients with destructive forms of pulmonary tuberculosis].
January 1974, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Efficiency of massive antibacterial therapy in patients with far advanced destructive forms of pulmonary tuberculosis].
January 1966, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Assessment of the status of patients with destructive forms of pulmonary tuberculosis].
November 1969, Vrachebnoe delo,
V T Kornienko, and L A Taranenko
[Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
January 1989, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
July 1983, Problemy tuberkuleza,
V T Kornienko, and L A Taranenko
[Outcome of the disease in patients with destructive forms of pulmonary tuberculosis].
December 1966, Klinicheskaia meditsina,
Copied contents to your clipboard!